Jane Street
DSGN icon

Jane Street’s Design Therapeutics DSGN Stock Holding History

Jane Street’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,900
Closed -$102K – 11875
2025
Q4 		$102K Buy
+10,900
New +$85.3K ﹤0.01% 10178
2023
Q2 		– Sell
-40,000
Closed -$231K – 8843
2023
Q1 		$231K Hold
40,000
– – ﹤0.01% 7617
2022
Q4 		$410K Buy
+40,000
New +$542K ﹤0.01% 6480

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jane Street's DSGN Position: Q2 2026 in Review

Jane Street sold out of Design Therapeutics (DSGN) in Q2 2026, closing a stake of 103,902 shares — an estimated $1.11M sold.

Jane Street first reported a position in DSGN in Q2 2022 and held it in 12 quarters. The position peaked at $2.12M in Q4 2025. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Jane Street reported no remaining Design Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 103,902 Design Therapeutics shares in Q2 2026, an estimated $1.11M.
  • Jane Street first reported a position in Design Therapeutics in Q2 2022 and held it in 12 quarters.
  • Jane Street's Design Therapeutics position peaked at $2.12M in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.